Advertisement
Breast milk protein shows even more promise against bladder cancer in new clinical trial
Common protein found in human breast milk has been seen to quickly kill bladder tumour cells
4-MIN READ4-MIN
1
A potential cancer cure that uses a replica of a protein found in human breast milk has even greater results when given in higher doses, new clinical trials show.
Alpha1H is a drug synthesised from alpha-lactalbumin, the most common protein in human breast milk, bound to a fatty acid known as oleic acid. In a recent study, it showed complete or partial response in triggering rapid tumour-cell death in 88 per cent of early-stage bladder cancer tumours.
It was developed by Hamlet BioPharma, headed by Swedish professor Catharina Svanborg of Lund University Sweden, who made the accidental discovery of the breast milk molecule’s cancer-fighting potential in 1995.
There were more than 610,000 new bladder cancer cases and more than 220,000 deaths globally in 2022, according to the World Cancer Research Fund. China had the highest number of new cases, at more than 92,000, and 41,000 deaths. Bladder cancer has a high recurrence rate and there is no cure.
Select Voice
Select Speed
1x
AI-generated voice